<?xml version="1.0" encoding="UTF-8"?>
<p>Importantly, we coinfected our RMs during the early phase of SIV infection, before they were clinically symptomatic and prior to the onset of immunodeficiency. Although vaccine immunogenicity is known to be compromised in chronically HIV-infected individuals, our data further suggest that vaccine efficacy may be similarly compromised or biased during hyperacute infection.</p>
